These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alpha-adrenoceptor and dopamine receptor antagonists do not block the slow inhibitory postsynaptic potential in sympathetic ganglia. Cole AE; Shinnick-Gallagher P Brain Res; 1980 Apr; 187(1):226-30. PubMed ID: 6244069 [No Abstract] [Full Text] [Related]
4. Characteristics of the vascular dopamine receptor: comparison with other receptors. Goldberg LI; Kohli JD; Kotake AN; Volkman PH Fed Proc; 1978 Aug; 37(10):2396-402. PubMed ID: 354973 [No Abstract] [Full Text] [Related]
5. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised cat. Dallas S; Drew GM; Hilditch A J Cardiovasc Pharmacol; 1986; 8(1):116-25. PubMed ID: 2419673 [TBL] [Abstract][Full Text] [Related]
6. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation. Sharma A; Kulkarni SK Indian J Exp Biol; 1994 Mar; 32(3):176-9. PubMed ID: 8070837 [TBL] [Abstract][Full Text] [Related]
10. Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides. Kohli JD; Glock D; Goldberg LI Adv Biochem Psychopharmacol; 1982; 35():97-108. PubMed ID: 6756064 [No Abstract] [Full Text] [Related]
11. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors. Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667 [No Abstract] [Full Text] [Related]
12. [Effects of dopaminergic drugs on the concentrations of PGE2 and PGF2alpha in various brain regions]. Grasso AA; Millia CC; Rampello L; Reggio A; De Simone D; Bousquet E; Rapisarda E Boll Soc Ital Biol Sper; 1983 Jan; 59(1):58-64. PubMed ID: 6573881 [TBL] [Abstract][Full Text] [Related]
14. TL-350, an ergoline derivative with dopamine receptor agonist properties. Ilhan M; Long JP; Bhatnagar R; Flynn J; Cannon JG; Lee T J Pharmacol Exp Ther; 1984 Oct; 231(1):56-60. PubMed ID: 6548524 [TBL] [Abstract][Full Text] [Related]
15. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. Pucak ML; Grace AA J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424 [TBL] [Abstract][Full Text] [Related]
16. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion. Horn PT; Kohli JD; Goldberg LI J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639 [TBL] [Abstract][Full Text] [Related]
17. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo. Hasan F; Leonard BE Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724 [No Abstract] [Full Text] [Related]
18. Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline. Ilhan M; Long JP; Cannon JG J Pharmacol Exp Ther; 1984 Nov; 231(2):361-6. PubMed ID: 6149308 [TBL] [Abstract][Full Text] [Related]
19. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers. Hom GJ; Jandhyala BS J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837 [TBL] [Abstract][Full Text] [Related]
20. Radioreceptor labeling of pre- and postsynaptic dopamine receptors. Titeler M; Seeman P Adv Biochem Psychopharmacol; 1980; 24():159-65. PubMed ID: 6996440 [No Abstract] [Full Text] [Related] [Next] [New Search]